We believe hope truly keeps us going!
Still, we are not giving up. We found a specialist who gave us hope and kept looking for treatment and research. We came up against so many barriers: too old for certain studies, too rare for standard care. Then we heard about Ultragenyx and UX111, a one-time gene therapy for Sanfilippo type A. The FDA approved this treatment under the name FAYUVI on 17 September 2026. Research data give hope that it may slow the decline. Whether and when Muk can be treated, and what the outcome will be for her, are still uncertain. That is why we want to be prepared: delaying fundraising would cost precious time if treatment becomes possible for Muk.
And so we started this crowdfunding campaign. We want to give Muk the very best chance and do everything we can to avoid the terrible scenarios we have been told about. As parents, we want to do everything to give our daughter a chance. A chance of more time, of quality of life, of living.
Her strong personality
Muk is a fighter. She walks a little differently and uses short words, but radiates love in every cuddle, every dance and every song she sings. She understands people instinctively, even though she cannot always express herself clearly. We want to give her the best. Every child deserves that. And so does Muk.
Through Stichting Muk tegen Kinderdementie, we are working for Muk and all the other children facing this fight. This disease breaks the hearts of everyone around a child who has it. Wherever that can be changed — or perhaps even prevented in the future — we are glad to help!
Want to keep up with the latest developments? Follow us on social media.